Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T23:37:57.844Z Has data issue: false hasContentIssue false

Evaluating the factor structure and construct validity of the NIH toolbox in older adults, with a focus on cognitive normalcy and amnestic mild cognitive impairment: considerations for diversity, including insights from persons over 85 years of age and Black older Americans

Published online by Cambridge University Press:  16 December 2024

Savannah Rose*
Affiliation:
University of Michigan, Ann Arbor, MI, USA
Allyson Gergoire
Affiliation:
Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
Subhamoy Pal
Affiliation:
Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
Jonathan Reader
Affiliation:
Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
Arijit Bhaumik
Affiliation:
Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
Jerry Slotkin
Affiliation:
University of Delaware, Newark, DE, USA
Emily Ho
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Cindy J. Nowinski
Affiliation:
University of Delaware, Newark, DE, USA
Carol C Persad
Affiliation:
University of Michigan, Ann Arbor, MI, USA Michigan Medicine, Ann Arbor, MI, USA
Amanda Cook Maher
Affiliation:
University of Michigan, Ann Arbor, MI, USA Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
Sandy Weintraub
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Richard Gershon
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Bruno Giordani
Affiliation:
University of Michigan, Ann Arbor, MI, USA Michigan Medicine, Ann Arbor, MI, USA Michigan Alzheimer’s Disease Research Center, Ann Arbor, MI, USA
*
Corresponding author: Savannah Gwynne Rose; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Validated computerized assessments for cognitive functioning are crucial for older individuals and those at risk of cognitive decline. The National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) exhibits good construct validity but requires validation in diverse populations and for adults aged 85+. This study uses data from the Assessing Reliable Measurement in Alzheimer’s Disease and cognitive Aging study to explore differences in the factor structure of the NIHTB-CB for adults 85 and older, Black participants versus White participants, and those diagnosed as amnestic Mild Cognitive Impairment (aMCI) vs cognitively normal (CN).

Method:

Subtests from the NACC UDS-3 and NIHTB-CB were administered to 503 community-dwelling Black and White adults ages 55–99 (367 CN; 136 aMCI). Confirmatory factor analyses were used to investigate the original factor structure of NIHTB-CB that forms the basis for NIHTB-CD Index factor scores.

Results:

Factor analyses for all participants and some participant subsets (aMCI, White, 85+) substantiated the two anticipated factors (Fluid and Crystallized). However, while Black aMCI participants had the expected two-factor structure, for Black CN participants, the List Sorting Working Memory and Picture Sequence tests loaded on the Crystallized factor.

Conclusions:

Findings provide psychometric support for the NIHTB-CB. Differences in factor structure between Black CN individuals and Black aMCI individuals suggest potential instability across levels of cognitive impairment. Future research should explore changes in NIHTB-CB across diagnoses in different populations.

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided that no alterations are made and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use and/or adaptation of the article.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of International Neuropsychological Society

Introduction

Dementia is a pressing global issue, affecting 55 million people worldwide, with Alzheimer’s disease accounting for 60–70% of dementia cases (WHO, 2023). In the United States alone, approximately 6.7 million individuals have been diagnosed with Alzheimer’s Disease (AD) (Alzheimer’s Association, 2024). Notably, Black Americans are almost twice as likely to receive an AD diagnosis compared to their White counterparts (Weuve et al., Reference Weuve, Barnes, Mendes de Leon, Rajan, Beck, Aggarwal, Hebert, Bennett, Wilson and Evans2018), and this discrepancy is anticipated to rise. A systematic review of the prevalence of mild cognitive impairment (MCI) suggests that approximately 15.6% of people worldwide meet criteria for MCI, with 10.0% meeting criteria for amnestic MCI (aMCI; Bai et al., Reference Bai, Chen, Cai, Zhang, Cheung, Jackson, Sha, Xiang and Su2022). aMCI confers an increased risk for the later development of AD. Traditional in-person neuropsychological assessments have been the gold standard for diagnosing MCI and dementia. Computerized assessments that do not require a neuropsychologist to administer may offer a unique opportunity to extend care to underserved populations, including minorities and those in rural areas who may not be able to easily access in person services, while also expanding scoring paradigms to consider timing and accuracy-by-timing calculations. However, these computerized assessments might also exacerbate health disparities based on socioeconomic status, access to technology/stable internet connection, and lower overall computer literacy. This is of particular concern in older adults who may not be as comfortable with technology. Still, it is crucial to develop and validate computerized neuropsychological measures, particularly with a focus on aging populations and racial minority populations. This paper aims to offer psychometric support for the use of the tablet-administered National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB), a computerized assessment tool for crystallized and fluid cognition, within the diverse and extensive sample of the Advancing Reliable Measurement in Alzheimer’s Disease and cognitive Aging (ARMADA) study.

As advanced age increases the risk for the development of MCI and dementia particularly AD, validating measures of cognitive functioning for use in adults over the age of 85 is particularly important, as this group has over a 33% risk of developing AD (Rajan et al., Reference Rajan, Weuve, Barnes, McAninch, Wilson and Evans2021). Additionally, research has identified neural dedifferentiation (decreased specialization of brain regions and networks activated during different cognitive tasks; Koen et al., Reference Koen, Srokova and Rugg2020) and cognitive dedifferentiation (i.e., the increased reliance on generalized intelligence to complete disparate cognitive tasks) as factors contributing to abnormal cognitive decline even after age, sex and education are accounted for (Wallert et al., Reference Wallert, Rennie, Ferreira, Muehlboeck, Wahlund, Westman and Ekman2021). Still the relationship between age and both cognitive dedifferentiation and neural dedifferentiation suggests that the factor structure of our neuropsychological instruments may be different or possibly less discrete (i.e., fewer factors or more cross loadings) for adults over the age or 85 as compared to the factor structure in older adults less than 85 years of age.

The NIHTB-CB is a module within the larger computerized NIH Toolbox for Assessment of Neurological and Behavioral Function and was developed to establish a common metric for cross-study comparisons of crystallized and fluid cognition (Gershon et al., Reference Gershon, Wagster, Hendrie, Fox, Cook and Nowinski2013; Weintraub et al., Reference Weintraub, Dikmen, Heaton, Tulsky, Zelazo, Slotkin, Carlozzi, Bauer, Wallner-Allen, Fox, Havlik, Beaumont, Mungas, Manly, Moy, Conway, Edwards, Nowinski and Gershon2014). While the computerized administration of the NIHTB-CB may enhance the accessibility of neuropsychological assessment for underserved populations, the validity of these scores must be established to determine clinical and research utility.

Prior studies evaluating the NIHTB-CB have demonstrated validity and clinical utility across diverse populations, including adults aged 20–85, healthy older adults aged 60–80 (Scott, E. P., Sorrell, A., & Benitez, A., Reference Scott, Sorrell and Benitez2019), children aged 3–15 (Weintraub et al., Reference Weintraub, Bauer, Zelazo, Wallner‐Allen, Dikmen, Heaton, Tulsky, Slotkin, Blitz, Carlozzi, Havlik, Beaumont, Mungas, Manly, Borosh, Nowinski and Gershon2013), stroke patients (Carlozzi et al., Reference Carlozzi, Goodnight, Casaletto, Goldsmith, Heaton, Wong, Baum, Gershon, Heinemann and Tulsky2017), and individuals with Mild Cognitive Impairment (MCI) and Dementia (Hackett et al., Reference Hackett, Krikorian, Giovannetti, Melendez‐Cabrero, Rahman, Caesar, Chen, Hristov, Seifan, Mosconi and Isaacson2018). Research has also shown validity for older adults up to age 85, providing evidence of convergent validity of NIHTB-CB index scores with gold standard instruments of cognitive functioning, excellent sensitivity to age-related cognitive changes, and excellent test-retest reliability (Parsey, Bagger, Trittschuh, & Hanson., Reference Parsey, Bagger, Trittschuh and Hanson2021; Zelazo et al., Reference Zelazo, Anderson, Richler, Wallner-Allen, Beaumont, Conway, Gershon and Weintraub2014). The NIHTB-CB has demonstrated external validity through strong correlations with factors such as self-reported school difficulties, health status, and disability status (Heaton et al., Reference Heaton, Akshoomoff, Tulsky, Mungas, Weintraub, Dikmen, Beaumont, Casaletto, Conway, Slotkin and Gershon2014). However, the measure has not been validated for use in adults over the age of 85.

Regarding the validity of the NIHTB-CB for use in the Black American population, some studies support its use as an assessment of premorbid IQ in Black older adults with and without MCI (Halter et al., Reference Halter, Moll, Kero, Kavcic, Woodard and Giordani2024). Other studies advocate for the development and use of demographically corrected norms for nonwhite patients (Flores et al., Reference Flores, Casaletto, Marquine, Umlauf, Moore, Mungas, Gershon, Beaumont and Heaton2017). Though these demographically corrected norms would likely be most appropriate for clinical/diagnostic uses of the NIHTB-CB and would not be necessary in every case, these studies underscore the need for continued research into the validity of the NIHTB-CB for nonwhite patients.

The two-factor (Crystallized and Fluid) structure of the NIHTB-CB proposed in Weintraub et al. (Reference Weintraub, Bauer, Zelazo, Wallner‐Allen, Dikmen, Heaton, Tulsky, Slotkin, Blitz, Carlozzi, Havlik, Beaumont, Mungas, Manly, Borosh, Nowinski and Gershon2013) has been investigated in prior studies and has been shown to have good model fit for adults over the age of 65, across diagnostic groups (cognitively unimpaired vs dementia/aMCI, across sex (male vs. female), and across majority and minority racial groups (underrepresented groups, vs non underrepresented groups; Ma et al., Reference Ma, Carlsson, Wahoske, Blazel, Chappell, Johnson, Asthana and Gleason2021). This study also showed some support for the invariance of this factor structure across diagnosis and demographic factors (i.e., sex, race, and education; Ma et al., Reference Ma, Carlsson, Wahoske, Blazel, Chappell, Johnson, Asthana and Gleason2021). However, a study investigating the factor structure of the NIHTB-CB in cognitively normal older adults over the age of 85 showed support for a six-factor structure (vocabulary, reading, memory, working memory, executive functioning and speed) rather than the proposed two-factor structure or other structure models (Nolin et al., Reference Nolin, Cowart, Merritt, McInerney, Bharadwaj, Franchetti, Raichlen, Jessup, Hishaw, Van Etten, Trouard, Geldmacher, Wadley, Porges, Woods, Cohen, Levin, Rundek, Alexander and Visscher2023). An evaluation of the NIHTB-CB factor structure in adults (aged 18–84) with and without acquired brain injury found support for a five-factor model (vocabulary, reading, episodic memory, working memory, and executive functioning/processing speed; Tulsky et al., Reference Tulsky, Holdnack, Cohen, Heaton, Carlozzi, Wong, Boulton and Heinemann2017). This variability underscores the need for continued evaluation of the NIHTB-CB factor structure in different samples.

This study aims to contribute to the existing literature by examining the two-factor structure of the NIHTB-CB (Weintraub et al., Reference Weintraub, Bauer, Zelazo, Wallner‐Allen, Dikmen, Heaton, Tulsky, Slotkin, Blitz, Carlozzi, Havlik, Beaumont, Mungas, Manly, Borosh, Nowinski and Gershon2013) across different stages of cognitive impairment, specifically Cognitively Normal (CN) and aMCI, and in different populations, with special attention to Black American populations and older adults over the age of 85 using the ARMADA dataset. In line with prior literature (Ma et al., Reference Ma, Carlsson, Wahoske, Blazel, Chappell, Johnson, Asthana and Gleason2021) we hypothesized that a two-factor structure (Crystallized and Fluid) would emerge and would remain stable across racial groups, diagnostic groups, and in the population over age 85.

Methods

This study was conducted in accordance with the Helsinki Declaration and the Institutional Review Boards of the University of Michigan Medical School.

Participants

A total of 503 community-dwelling older adults were recruited from 2018–2022 as part of the ARMADA study. Data were collected across 9 sites, with most participants in this study co-enrolled in Alzheimer’s Disease Research Centers (ADRCs). Informed consent was obtained from all participants at the appropriate ADRCs. Participants underwent a comprehensive evaluation using the NACC UDS-3, involving multidomain medical, neurological, social, and neuropsychological assessments. Participants received diagnoses of CN or aMCI through consensus conferences based on NACC criteria (Rahman-Filipiak et al., Reference Rahman-Filipiak, Sadaghiyani, Davis, Bhaumik, Paulson, Giordani and Hampstead2022; Weintraub et al., Reference Weintraub, Besser, Dodge, Teylan, Ferris, Goldstein, Giordani, Kramer, Loewenstein, Marson, Mungas, Salmon, Welsh-Bohmer, Zhou, Shirk, Atri, Kukull, Phelps and Morris2018; Weintraub et al., Reference Weintraub, Salmon, Mercaldo, Ferris, Graff-Radford, Chui, Cummings, DeCarli, Foster, Galasko, Peskind, Dietrich, Beekly, Kukull and Morris2009) at their specific ADRCs. After receiving a consensus diagnosis, participants completed the tablet-based NIHTB-CB. The average time between NACC evaluation/consensus diagnosis and NIHTB-CB administration was 130 days. Only the baseline NIHTB uncorrected standard score data were used in the analyses reported here, along with consideration of appropriate adjustments based on ARMADA demographic values.

Our sample consisted of two diagnostic groups: 367 CN and 136 participants diagnosed with aMCI. The sample did not include participants with Alzheimer’s disease (AD), as sufficient samples of Black participants were not available. The sample was approximately 59% female and 30% Black. Ages ranged from 65 to 99 years, with an average age of 77.26 (SD = 7.8). Education was between 8 and 20 years, with a mean of 16.3 years (SD = 2.5). Sample demographics by racial and demographic group can be found in Table 1.

Table 1. Demographics

Measures

NIH Toolbox-Cognition Battery

The NIHTB-CB is a performance-based mobile application (NIH Toolbox v.2, Toolbox Assessments, Chicago, IL) designed to assess cognitive functioning using an iPad tablet. Internet connectivity is not required for NIHTB-CB administration or scoring. The battery has seven subtests and was designed to be completed within 30 mins. The seven subtests measure performance on crystallized cognition, assessed by language-dependent abilities (Oral Reading Recognition [ORR] and Picture Vocabulary [PV]), and fluid cognition, which assesses executive function (Dimensional Change Card Sort [DCCS]), attention and executive ability (Flanker Inhibitory Control and Attention [Flanker]), working memory (List Sorting Working Memory [LSWM]), processing speed (Pattern Comparison Processing Speed [PC]), and episodic memory (Picture Sequence Memory [PSM]). Performance is measured with either unadjusted normative scale scores (standard scores) or fully corrected (age and education adjusted) normative scores (T scores). Specific test details, procedures, and extensive psychometrics are found in Weintraub et al. (Reference Weintraub, Bauer, Zelazo, Wallner‐Allen, Dikmen, Heaton, Tulsky, Slotkin, Blitz, Carlozzi, Havlik, Beaumont, Mungas, Manly, Borosh, Nowinski and Gershon2013).

Statistical analyses

A series of two-factor confirmatory factor analyses (CFA) were used to investigate the factor structure of the NIHTB-CB for the entire sample, race (White vs Black), diagnosis (aMCI vs CN) and age greater than 85. Additional CFAs were run investigating the factor structure in Black and White participants diagnosed as CN vs. aMCI. Following the recommendations of the NIHTB-CB developers, uncorrected standard scores were used in these analyses.

Results

Factor analyses

A series of CFA’s were conducted to examine the factor structure of the NIHTB-CB for the entire sample, participants diagnosed with aMCI, and participants over the age of 85. Additional factor analyses were conducted to investigate variations in factor structure by race (all Black vs. all White participants) and for Black participants across diagnostic classifications (CN and aMCI). Each group showed a two-factor model with relatively good fit (CFI/TLI > 0.95; RMSEA < .07; Browne & Cudeck, Reference Browne, Cudeck, Bollen and Long1993, Hu & Bentler, Reference Hu and Bentler1999; Jöreskog & Sörbom, Reference Jöreskog and Sörbom1993) and factor loadings greater than 0.4 (Stevens, Reference Stevens1992). For detailed information on model fit by each subsample please see Table 2. Nearly all factor analyses substantiated the two anticipated factors: Fluid and Crystallized. The Fluid factor included Flanker, DCCS, PC, LSWM, and PSM, while the Crystallized factor included PV and ORR. This factor structure was also replicated for participants over the age of 85.

Table 2. Factor Loadings by Subsample

In the full subsample of Black participants, a two-factor model also emerged; however, PSM loaded onto the Crystallized factor rather than Fluid factor. Similar deviations in factor loadings were observed when examining the factor structure in Black CN participants, where List Sort Working Memory and PSM loaded onto the Crystallized factor rather than the Fluid factor. Interestingly, in Black participants with aMCI, the original factor structure and loading pattern were successfully replicated. It is also important to note that of all NIHTB-CB measures, PSM followed by List Sort Working Memory showed the lowest factor loadings in all subsequent samples. See Table 2 for all factor loadings by analysis.

Discussion

Our study successfully replicated the proposed two-factor structure of the NIHTB-CB across various subgroups, including the general sample, Black and White participants, individuals over the age of 85, and participants diagnosed as CN or with aMCI. These results offer psychometric support for the validity of the NIHTB-CB in these diverse populations. However, when examining the factor structure of the NIHTB-CB in Black participants identified as CN, a slight deviation was observed compared to White participants, with List Sort Working Memory and PSM loading onto the Crystallized factor rather than the Fluid factor. Interestingly, this difference was not evident when exploring the factor structure for Black participants diagnosed with MCI. It suggests that there are cultural differences that may impact the way CN Black participants interact with NIHTB-CB measures (possibly increased use of verbal mediation or verbal processing strategies) that are then attenuated by cognitive impairment (i.e., MCI). This finding also suggests potential instability in the factor structure of the NIHTB-CB across different levels of cognitive impairment for Black participants. Furthermore, considering that 10–15% of participants diagnosed with MCI progress to dementia (McGrattan et al., Reference McGrattan, Pakpahan, Siervo, Mohan, Reidpath, Prina, Allotey, Zhu, Shulin, Yates, Paddick, Robinson and Stephan2022), the generally lower factor loading of PSM in all analyses and the differences in factor structure in Black participants across diagnostic categories over time suggests that the Fluid composite may not be as stable as would be expected within a given individual as cognitive impairment progresses. Clinicians and researchers should be mindful of this potential instability in the factor structure across different levels of cognitive impairment, particularly if using the NIHTB-CB to assess for cognitive decline (particularly in memory compared to executive functioning or other fluid measures) over time in Black individuals. While unlikely to strongly influence diagnostic conclusions, the fact that the relationship between PSM and other fluid measures changes across cognitive diagnoses is an important factor to consider when interpreting patterns of cognitive weakness (i.e., aMCI vs MCI). As memory is not considered a crystalized ability and is sensitive to cognitive change, the fact that PSM loaded onto the crystalized factor also raises some concern for the stability of the NIHTB-CB crystalized composite. Indeed, previous studies identified that measures of crystallized intelligence (ORR and PV) were sensitive in differentiating MCI Black participants from healthy controls when compared to memory and executive measures (Kairys et al., Reference Kairys, Daugherty, Kavcic, Shair, Persad, Heidebrink, Bhaumik and Giordani2022; Rigby et al., Reference Rigby, Gregoire, Reader, Kahsay, Fisher, Kairys, Bhaumik, Rahman-Filipiak, Maher, Hampstead, Heidebrink, Kavcic and Giordani2024). Taken together, these findings further suggest that NIHTB-CB crystalized measures may be differentially related to cognitive decline and may not represent a cognitive “hold” factor as previously thought (Jutten et al., Reference Jutten, Ho, Karpouzian-Rogers, Van Hulle, Carlsson, Dodge., Nowinski, Gershon, Weintraub and Rentz2024), particularly in different racial groups.

This study is among the first to explore the factor structure of the NIHTB-CB with regard to adults over the age of 85 and Black participants. Given the higher risk of developing AD among Black older adults (Weuve et al., Reference Weuve, Barnes, Mendes de Leon, Rajan, Beck, Aggarwal, Hebert, Bennett, Wilson and Evans2018), validating easily accessible neuropsychological assessments becomes crucial for early detection of AD and increases access to neuropsychological assessment and diagnosis in a historically underserved population. The present findings contribute to research evaluating the utility of the NIHTB-CB in diverse populations.

However, this study is not without limitations. While the ARMADA study enables the collection and comparison of cognitive assessment data over time, we did not specifically investigate the temporal stability of the NIHTB-CB factor structure. Based on our findings, a more thorough investigation of the factor invariance of the NIHTB-CB for different demographic groups and diagnostic categories is also warranted. These represent important avenues for future research, especially in light of observed differences in factor structure between Black participants with CN and MCI. MCI participants in our study were of the amnestic type, as this confers the highest risk for development of Alzheimer’s disease. However, it is worth noting that non-amnestic MCI may not follow this same pattern as aMCI, and further research should evaluate differences in factor structure in these populations. It is also important to note that the sample gathered through the ARMADA study is highly educated compared to the general population and these findings may not generalize to populations with lower levels of education. Despite these limitations, our study provides robust validity coefficients, supporting the overall utility of the NIHTB-CB and contributing valuable insights to the ongoing exploration of its validity.

Funding statement

This project was supported by the ‘Assessing Reliable Measurement in Alzheimer’s Disease and Cognitive Aging’ project (ARMADA), U2CAG057441, sponsored by the NIA (MPIs Richard Gershon and Sandra Weintraub), The NIA/NIH R01AG068338 (MPI’s Giordani, Persad, Murphey); the NIA/NIH grant P30AG053760; and NIA/NIH grant P30AG072931 (PI, Henry Paulson).

Competing interests

The authors have no conflicts of interest to disclose.

References

Alzheimer’s Association. (2024). Alzheimer’s Disease facts and figures. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf Google Scholar
Bai, W., Chen, P., Cai, H., Zhang, Q., Cheung, T., Jackson, T., Sha, S., Xiang, Y.-T., & Su, Z. (2022). Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older a meta analysis and systematic review of epidemiology studies. Age and ageing, 51, afac173.Google Scholar
Browne, M. W., & Cudeck, R. (1993). Alternative ways of assessing model fit. In Bollen, K. A., & Long, J. S. (Eds.), Testing structural equation models (pp. 136162). Sage.Google Scholar
Carlozzi, N. E., Goodnight, S., Casaletto, K. B., Goldsmith, A., Heaton, R. K., Wong, A. W. K., Baum, C. M., Gershon, R., Heinemann, A. W., & Tulsky, D. S. (2017). Validation of the NIH toolbox in individuals with neurologic disorders. Archives of Clinical Neuropsychology, 32, 555573.CrossRefGoogle ScholarPubMed
Flores, I., Casaletto, K. B., Marquine, M. J., Umlauf, A., Moore, D. J., Mungas, D., Gershon, R. C., Beaumont, J. L., & Heaton, R. K. (2017). Performance of hispanics and non-hispanic Whites on the NIH Toolbox Cognition Battery: The roles of ethnicity and language backgrounds. The Clinical Neuropsychologist, 31, 783797.CrossRefGoogle ScholarPubMed
Gershon, R. C., Wagster, M. V., Hendrie, H. C., Fox, N. A., Cook, K. F., & Nowinski, C. J. (2013). NIH toolbox for assessment of neurological and behavioral function. Neurology, 80, S2S6.CrossRefGoogle ScholarPubMed
Hackett, K., Krikorian, R., Giovannetti, T., Melendez‐Cabrero, J., Rahman, A., Caesar, E. E., Chen, J. L., Hristov, H., Seifan, A., Mosconi, L., & Isaacson, R. S. (2018). Utility of the NIH Toolbox for assessment of prodromal Alzheimer’s disease and dementia. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 10, 764772.Google ScholarPubMed
Halter, C. M., Moll, A. C., Kero, K., Kavcic, V., Woodard, J. L., & Giordani, B. (2024). Construct validation of NIH Toolbox Cognition Battery premorbid cognitive functioning scores in Black and White older Americans with and without mild cognitive impairment. Journal of the International Neuropsychological Society : JINS, 30, 194198. https://doi.org/10.1017/S1355617723000425 CrossRefGoogle ScholarPubMed
Heaton, R. K., Akshoomoff, N., Tulsky, D., Mungas, D., Weintraub, S., Dikmen, S., Beaumont, J., Casaletto, K. B., Conway, K., Slotkin, J., & Gershon, R. (2014). Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults. Journal of the International Neuropsychological Society: JINS, 20, 588598. https://doi.org/10.1017/S1355617714000241 CrossRefGoogle ScholarPubMed
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal, 6, 155.CrossRefGoogle Scholar
Jöreskog, K. G., & Sörbom, D. (1993). Lisrel 8: Structural equation modeling with the simplis command language.Google Scholar
Jutten, R. J., Ho, E. H., Karpouzian-Rogers, T., Van Hulle, C., Carlsson, C., Dodge., H. H., Nowinski, C. J., Gershon, R., Weintraub, S., & Rentz, D. M. (2024). Computerized cognitive testing to capture cognitive decline in Alzheimer’s disease: Longitudinal findings from the ARMADA study. [Manuscript submitted for publication].Google Scholar
Kairys, A., Daugherty, A., Kavcic, V., Shair, S., Persad, C., Heidebrink, J., Bhaumik, A., & Giordani, B. (2022). Laptop-administered NIH toolbox and cogstate brief battery in community-dwelling Black adults: Unexpected pattern of cognitive performance between MCI and healthy controls. Journal of the International Neuropsychological Society : JINS, 28, 239248.CrossRefGoogle ScholarPubMed
Koen, J. D., Srokova, S., & Rugg, M. D. (2020). Age-related neural dedifferentiation and cognition. Current Opinion in Behavioral Sciences, 32, 714.CrossRefGoogle ScholarPubMed
Ma, Y., Carlsson, C. M., Wahoske, M. L., Blazel, H. M., Chappell, R. J., Johnson, S. C., Asthana, S., & Gleason, C. E. (2021). Latent factor structure and measurement invariance of the NIH Toolbox Cognition Battery in an Alzheimer’s disease research sample. Journal of the International Neuropsychological Society: JINS, 27, 412425.CrossRefGoogle Scholar
McGrattan, A. M., Pakpahan, E., Siervo, M., Mohan, D., Reidpath, D. D., Prina, M., Allotey, P., Zhu, Y., Shulin, C., Yates, J., Paddick, S.M., Robinson, L., Stephan, B. C. M., & DePEC team (2022). Risk of conversion from mild cognitive impairment to dementia in low‐ and middle‐income countries: A systematic review and meta‐analysis. Alzheimer’s & dementia, (New York, N. Y.), 8, e12267.Google ScholarPubMed
Nolin, S. A., Cowart, H., Merritt, S., McInerney, K., Bharadwaj, P. K., Franchetti, M. K., Raichlen, D. A., Jessup, C. J., Hishaw, G. A., Van Etten, E. J., Trouard, T. P., Geldmacher, D. S., Wadley, V. G., Porges, E. S., Woods, A. J., Cohen, R. A., Levin, B. E., Rundek, T., Alexander, G. E., & Visscher, K. M. (2023). Validity of the NIH toolbox cognitive battery in a healthy oldest-old 85+ sample. Journal of the International Neuropsychological Society: JINS, 29, 605614.CrossRefGoogle Scholar
Parsey, C. M., Bagger, J. E., Trittschuh, E. H., & Hanson, A. J. (2021). Utility of the iPad NIH Toolbox Cognition Battery in a clinical trial of older adults. Journal of the American Geriatrics Society, 69, 35193528.CrossRefGoogle Scholar
Rahman-Filipiak, A., Sadaghiyani, S., Davis, K., Bhaumik, A. K., Paulson, H. L., Giordani, B., & Hampstead, B. M. (2022). Validation of the National Alzheimer’s Coordinating Center (NACC) lewy body disease module neuropsychological tests. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 14, e12279.Google Scholar
Rajan, K. B., Weuve, J., Barnes, L. L., McAninch, E. A., Wilson, R. S., & Evans, D. A. (2021). Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimer’s & dementia : The journal of the Alzheimer’s Association, 17, 19661975.CrossRefGoogle ScholarPubMed
Rigby, T., Gregoire, A. M., Reader, J., Kahsay, Y., Fisher, J., Kairys, A., Bhaumik, A. K., Rahman-Filipiak, A., Maher, A. C., Hampstead, B. M., Heidebrink, J. L., Kavcic, V., & Giordani, B. (2024). Identification of amnestic mild cognitive impairment among Black and White community-dwelling older adults using NIH toolbox cognition tablet battery. Journal of the International Neuropsychological Society: JINS, 30, 689696.CrossRefGoogle ScholarPubMed
Scott, E. P., Sorrell, A., & Benitez, A. (2019). Psychometric properties of the NIH Toolbox Cognition Battery in healthy older adults: Reliability, validity, and agreement with standard neuropsychological tests. Journal of the International Neuropsychological Society: JINS, 25, 857867.CrossRefGoogle ScholarPubMed
Stevens, J. (1992). Applied Multivariate Statistics for the Social Sciences. 2nd edition.Google Scholar
Tulsky, D. S., Holdnack, J. A., Cohen, M. L., Heaton, R. K., Carlozzi, N. E., Wong, A. W. K., Boulton, A. J., & Heinemann, A. W. (2017). Factor structure of the NIH Toolbox Cognition Battery in individuals with acquired brain injury. Rehabilitation Psychology, 62, 435442.CrossRefGoogle ScholarPubMed
Wallert, J., Rennie, A., Ferreira, D., Muehlboeck, J.-S., Wahlund, L.-O., Westman, E., Ekman, U., & ADNI consortium, and MemClin steering committee (2021). Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts. Aging, 13, 1343013442.CrossRefGoogle Scholar
Weintraub, S., Bauer, P. J., Zelazo, P. D., Wallner‐Allen, K., Dikmen, S. S., Heaton, R. K., Tulsky, D. S., Slotkin, J., Blitz, D. L., Carlozzi, N. E., Havlik, R. J., Beaumont, J. L., Mungas, D., Manly, J. J., Borosh, B. G., Nowinski, C. J., & Gershon, R. C. (2013). I. NIH Toolbox Cognition Battery (CB): Introduction and pediatric data. Monographs of the Society for Research in Child Development, 78, 115.CrossRefGoogle ScholarPubMed
Weintraub, S., Besser, L., Dodge, H. H., Teylan, M., Ferris, S., Goldstein, F. C., Giordani, B., Kramer, J., Loewenstein, D., Marson, D., Mungas, D., Salmon, D., Welsh-Bohmer, K., Zhou, X.-H., Shirk, S. D., Atri, A., Kukull, W. A., Phelps, C., & Morris, J. C. (2018). Version 3 of the Alzheimer disease centers’ neuropsychological test battery in the Uniform Data Set (UDS), Alzheimer Disease and Associated Disorders, 32, 1017.CrossRefGoogle ScholarPubMed
Weintraub, S., Dikmen, S. S., Heaton, R. K., Tulsky, D. S., Zelazo, P. D., Slotkin, J., Carlozzi, N. E., Bauer, P. J., Wallner-Allen, K., Fox, N., Havlik, R., Beaumont, J. L., Mungas, D., Manly, J. J., Moy, C., Conway, K., Edwards, E., Nowinski, C. J., & Gershon, R. (2014). The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: Validation in an adult sample. Journal of the International Neuropsychological Society: JINS, 20, 567578.CrossRefGoogle Scholar
Weintraub, S., Salmon, D., Mercaldo, N., Ferris, S., Graff-Radford, N. R., Chui, H., Cummings, J., DeCarli, C., Foster, N. L., Galasko, D., Peskind, E., Dietrich, W., Beekly, D. L., Kukull, W. A., & Morris, J. C. (2009). The Alzheimer’s Disease Centers’ Uniform Data Set (UDS). Alzheimer Disease and Associated Disorders, 23, 91101.CrossRefGoogle ScholarPubMed
Weuve, J., Barnes, L. L., Mendes de Leon, C. F., Rajan, K. B., Beck, T., Aggarwal, N. T., Hebert, L. E., Bennett, D. A., Wilson, R. S., & Evans, D. A. (2018). Cognitive aging in Black and White Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology (Cambridge, Mass.), 29, 151159.CrossRefGoogle ScholarPubMed
Zelazo, P. D., Anderson, J. E., Richler, J., Wallner-Allen, K., Beaumont, J. L., Conway, K. P., Gershon, R., & Weintraub, S. (2014). NIH Toolbox Cognition Battery (CB): Validation of executive function measures in adults. Journal of the International Neuropsychological Society : JINS, 20, 620629.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Demographics

Figure 1

Table 2. Factor Loadings by Subsample